Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SmartPhage

SmartPhage?uq=UG6efJS6
2016 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of precise therapies designed to defense against antibiotic resistance. The company's automated platform offers to build the equivalent of a smart missile for infections which is aggressive but highly targeted, enabling researchers to successfully develop and test new therapies to counter diseases.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Palo Alto, CA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SmartPhage’s full profile, request a free trial.

SmartPhage Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 00000 Completed Out of Business
3. Seed Round 29-Nov-2017 00000 00000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 22-Mar-2017 $5K $105K 00000 Completed Generating Revenue
1. Accelerator/Incubator $100K $100K 000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

SmartPhage Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

SmartPhage Executive Team (2)

Name Title Board
Seat
Contact
Info
Nathan Brown Principal Scientist
Job Shiach Co-Founder & Vice President, Research